Myriad Genetics Delivers 12% Sequential Revenue Growth in March 2021 Quarter, Company Executes on Strategic Transformation Initiatives
Go back to Myriad Genetics Delivers 12% Sequential Revenue Growth in March 2021 Quarter, Company Executes on Strategic Transformation Initiatives| Illumina, Inc. (NASDAQ: ILMN) | Delayed: 161.38 -0.55 (0.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $161.93 | 52 Week High | $196.47 | |||
| Open | $161.83 | 52 Week Low | $127.10 | |||
| Day High | $163.79 | P/E | 179.31 | |||
| Day Low | $158.91 | EPS | $0.90 | |||
| Volume | 1,791,115 | |||||
| Laboratory Corp. of America Holding (NYSE: LH) | Delayed: 254.43 -1.39 (0.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $255.82 | 52 Week High | $141.32 | |||
| Open | $254.13 | 52 Week Low | $97.79 | |||
| Day High | $256.73 | P/E | 40.71 | |||
| Day Low | $253.05 | EPS | $6.25 | |||
| Volume | 784,900 | |||||
| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 4.50 -0.04 (0.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.54 | 52 Week High | $45.34 | |||
| Open | $4.54 | 52 Week Low | $15.92 | |||
| Day High | $4.62 | P/E | 1.93 | |||
| Day Low | $4.42 | EPS | $2.33 | |||
| Volume | 1,271,242 | |||||

